Literature DB >> 15700767

Effects of melatonin on carbon tetrachloride-induced changes in rat serum.

M Ogeturk1, I Kus, A Kavakli, I Zararsiz, N Ilhan, M Sarsilmaz.   

Abstract

Carbon tetrachloride (CCl4) is a volatile organic chemical, which causes tissue damage, especially to the liver and kidney. In experimental animals it has been shown to be carcinogenic. This study was designed to evaluate the effects of exogenous melatonin administration on the CCl4-induced changes of some biochemical parameters in rat blood. Twenty-four male Wistar rats were randomly divided into three equal groups: Control, CCl4 and CCl4 plus melatonin (CCl4+MEL). Rats in CCl4 group were injected subcutaneously with CCl4 0.5 ml/kg in olive oil while rats in CCl4+MEL group were injected with CCl4 (0.5 ml/kg) plus melatonin (25 mg/kg in 10% ethanol) every other day for one month. Control rats were treated with olive oil. Serum urea, creatinine, total protein, albumin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), total and conjugated bilirubin, alkaline phosphatase (ALP), gamma-glutamyl transferase (gamma-GT), total iron, and magnesium levels were determined. Serum AST, ALT, total and conjugated bilirubin, ALP, gamma-GT, and total iron levels were significantly higher in CCl4-treated rats than in the controls, while urea, total protein, and albumin levels were significantly lower. Melatonin treatment did not cause a significantly change in serum urea, total protein, and albumin levels. However, the elevations in AST, ALT, total and conjugated bilirubin, ALP, gamma-GT, and total iron levels induced by CCl4 injections were significantly reduced by melatonin. On the other hand, melatonin administration significantly decreased serum magnesium levels. These results indicate that melatonin could be a protective agent against the CCl4 toxicity in rats, most likely through its antioxidant and free radical scavenger effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15700767     DOI: 10.1007/bf03167030

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  30 in total

1.  Pharmacokinetics of diaspirin cross-linked haemoglobin in a rat model of hepatic cirrhosis.

Authors:  R Palaparthy; H Kastrissios; A Gulati
Journal:  J Pharm Pharmacol       Date:  2001-02       Impact factor: 3.765

2.  A massive increase in serum beta-glucuronidase after a single dose of carbon tetrachloride to the rat.

Authors:  Premila Abraham; G Wilfred
Journal:  Clin Chim Acta       Date:  2002-08       Impact factor: 3.786

3.  Comparison of the protective effect of melatonin with other antioxidants in the hamster kidney model of estradiol-induced DNA damage.

Authors:  M Karbownik; R J Reiter; J Cabrera; J J Garcia
Journal:  Mutat Res       Date:  2001-03-01       Impact factor: 2.433

Review 4.  Pharmacological actions of melatonin in oxygen radical pathophysiology.

Authors:  R Reiter; L Tang; J J Garcia; A Muñoz-Hoyos
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

5.  Effect of methoxyindole administration on plasma cation levels in the rat.

Authors:  D J Morton
Journal:  J Pineal Res       Date:  1989       Impact factor: 13.007

6.  The bradykinin B2 receptor antagonist Icatibant (HOE 140) corrects avid Na+ retention in rats with CCl4-induced liver cirrhosis: possible role of enhanced microvascular leakage.

Authors:  K J Wirth; M Bickel; M Hropot; V Günzler; H Heitsch; D Ruppert; B A Schölkens
Journal:  Eur J Pharmacol       Date:  1997-10-15       Impact factor: 4.432

7.  Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment.

Authors:  M L Seabra; M Bignotto; L R Pinto; S Tufik
Journal:  J Pineal Res       Date:  2000-11       Impact factor: 13.007

8.  Effects of black tea extract on carbon tetrachloride-induced lipid peroxidation in liver, kidneys, and testes of rats.

Authors:  Zaineb A Fadhel; Suham Amran
Journal:  Phytother Res       Date:  2002-03       Impact factor: 5.878

9.  Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal injury.

Authors:  Hakan Parlakpinar; Engin Sahna; M K Ozer; Fikret Ozugurlu; Nigar Vardi; Ahmet Acet
Journal:  J Pineal Res       Date:  2002-10       Impact factor: 13.007

10.  Evaluation of the antioxidant activity of melatonin in vitro.

Authors:  K A Marshall; R J Reiter; B Poeggeler; O I Aruoma; B Halliwell
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

View more
  5 in total

1.  Urinary metabolites and antioxidant products of exogenous melatonin in the mouse.

Authors:  Xiaochao Ma; Jeffrey R Idle; Kristopher W Krausz; Dun-Xian Tan; Leopoldo Ceraulo; Frank J Gonzalez
Journal:  J Pineal Res       Date:  2006-05       Impact factor: 13.007

2.  Dietary supplementation with melatonin: influence on growth performance, oxidative stress status, and amelioration of silver nanoparticles-induced toxicity in Nile tilapia (Oreochromis niloticus).

Authors:  Shakila Veisi; Mehrdad Sarkheil; Seyed Ali Johari; Omid Safari
Journal:  Trop Anim Health Prod       Date:  2021-05-10       Impact factor: 1.559

Review 3.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

4.  Effect of Melatonin as an Antioxidant Drug to Reverse Hepatic Steatosis: Experimental Model.

Authors:  Blanca Martínez Soriano; Antonio Güemes; Guillermo Pola; Azucena Gonzalo; Pilar Palacios Gasós; Ana C Navarro; Roberto Martínez-Beamonte; Jesús Osada; José J García
Journal:  Can J Gastroenterol Hepatol       Date:  2020-06-03

5.  Biochemical and histopathological study in rats intoxicated with carbontetrachloride and treated with camel milk.

Authors:  Thnaian Althnaian; Ibrahim Albokhadaim; Sabry M El-Bahr
Journal:  Springerplus       Date:  2013-02-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.